John L Lamattina

Director, Ligand Pharmaceuticals

Bought, 12 months

$0.0M

Sold, 12 months

$2.4M

Companies

Latest trade

Jun 10, 2026

Companies

Ligand PharmaceuticalsDirector −$2.4M

Trades

LGND Sold 4,591 shares at $250.88 $1.2M Jun 10

LGND Sold 2,161 shares at $200.76 $0.4M Mar 6

LGND Sold 4,179 shares at $205.45 $0.9M Nov 7

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.